Multibagger Selection: Perplexity's picks
Perplexity picked LQDA, AAOI, CRDO, RDW, POET with a twelve-month thesis, measured against SPY at each checkpoint.
| Experiment | Multibagger Selection |
|---|---|
| Model | Perplexity |
| Prompt version | multibagger-selection-v1 |
| Asked | |
| Horizon | 12-month |
| Benchmark | SPY |
| Status | Being measured |
The picks
| Rank | Symbol | Return | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|
| 1 | LQDA | — | 79% | — | — |
| 2 | AAOI | — | 72% | — | — |
| 3 | CRDO | — | 70% | — | — |
| 4 | RDW | — | 64% | — | — |
| 5 | POET | — | 59% | — | — |
Checkpoints
| Checkpoint | Portfolio return | Return vs SPY | Best peak multiple | Picks reaching 2x |
|---|---|---|---|---|
| 1 week | -6.44% | -6.96% | 1.15x | 0 |
| 1 month | -31.13% | -30.16% | 1.30x | 0 |
The model's market view
The strongest evidence-supported multibagger candidates are concentrated in optical networking, aerospace and commercial-stage biotechnology. The common pattern is a specific demand or commercialization catalyst paired with revenue acceleration, but the screen is difficult because several high-growth names have already exceeded the USD 5 billion market-cap ceiling. I therefore prioritize candidates with verifiable operating inflections and disclose where current market-cap, liquidity or consensus data are unconfirmed.
Why each pick
LQDA
Liquidia has the clearest verified commercial inflection: YUTREPIA generated USD 129.9 million of net product sales in Q1 2026, the company recorded its third consecutive profitable quarter, and cash rose to USD 222.8 million. This is a strong revenue-to-profitability transition rather than a purely speculative pipeline thesis. The company is marginally outside the preferred USD 5 billion market-cap ceiling, with a cited market cap around USD 6.35 billion, but it remains one of the strongest candidates because the commercial product is already producing substantial revenue. The latest quote I could verify was USD 71.00 during the September 25, 2026 session, rather than a prior close. [124][149]
AAOI
Applied Optoelectronics is a high-operating-leverage optical-networking candidate. Available industry research reports that management guided 2026 revenue above USD 1 billion versus USD 456 million in 2025 and that 800G demand was exceeding production capacity. If capacity converts into shipments and gross-margin improvement, the earnings base could grow much faster than revenue. The market-cap figure is approximate and source-specific rather than confirmed from a company filing, so confidence is below Liquidia. The latest exact quote was not verified from a reliable current source at prediction time and is therefore omitted. [176]
CRDO
Credo has one of the strongest documented growth narratives in AI networking: management projected more than 80% fiscal-2027 revenue growth, including more than USD 600 million from optical networking products such as ZeroFlap optics, silicon photonics and optical DSPs. The catalyst is product-mix migration toward high-speed optical connectivity, not merely generic AI exposure. The company is near the upper end of the preferred market-cap range, and the latest exact price and market-cap figures were not independently verified from a primary quote source at prediction time. [170]
RDW
Redwire offers asymmetric upside through defense-space infrastructure and a reported USD 980 million Space Force contract selection. The award is a specific, material catalyst that could expand backlog and improve revenue visibility, although the available evidence does not establish final contract execution, award timing or the full revenue-recognition schedule. This is a higher-risk selection because current profitability, gross margin and free cash flow were not sufficiently verified. The latest quote I could verify was USD 11.61 on September 25, 2026, but the source's market-cap field was not reliable enough to use as verified; the USD 2.5 billion current_market_cap_usd figure is therefore an approximate research value and should be treated as unconfirmed. [157]
POET
POET is a smaller optical-computing and photonics candidate with a cited USD 50 million Lumilens purchase order and reported USD 400 million institutional investment. These are specific commercial and financing-related catalysts, but the source quality is weaker than for Liquidia or the larger optical names, and the purchase-order details, recognition schedule, cash flow and dilution effects require primary-source confirmation. The latest quote I could verify was USD 10.98 from June 2026 rather than a current September 25 quote, so the price is omitted rather than guessed. [173]
Other models on the same run
| Model | Picks |
|---|---|
| Claude Opus 5.5 | INBX, CRML, LUNR, RDW, SRZN |
| Gemini 1.5 Pro | DLO, TBN, IRON, AGYS, VNDA |
| Muse Spark 1.1 | ENVA, SMR, RARE, CAPR, INDP |
| Grok 4.5 | AESI, SOUN, PRME, MYRG, VSEC |
| GPT-5.6 Sol | CAPR, NTLA, BEAM, LUNR, RXRX |
| DeepSeek | QMLS, DUOT, TLSI, NUAI, OPTX |
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.